135 related articles for article (PubMed ID: 7529409)
1. Screening for prostate cancer.
Waldman AR; Osborne DM
Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
[TBL] [Abstract][Full Text] [Related]
2. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
Mettlin C; Murphy GP; Babaian RJ; Chesley A; Kane RA; Littrup PJ; Mostofi FK; Ray PS; Shanberg AM; Toi A
Cancer; 1996 Jan; 77(1):150-9. PubMed ID: 8630923
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men.
Gustafsson O; Carlsson P; Norming U; Nyman CR; Svensson H
Prostate; 1995 Jun; 26(6):299-309. PubMed ID: 7540297
[TBL] [Abstract][Full Text] [Related]
4. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
[TBL] [Abstract][Full Text] [Related]
5. [Screening of prostate carcinoma].
Trinkler FB
Ther Umsch; 1995 Jun; 52(6):393-8. PubMed ID: 7541568
[TBL] [Abstract][Full Text] [Related]
6. Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen.
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Tumori; 1995; 81(4):225-9. PubMed ID: 8540115
[TBL] [Abstract][Full Text] [Related]
7. The American Cancer Society's National Prostate Cancer Detection Project.
Littrup PJ
Can J Oncol; 1994 Nov; 4 Suppl 1():65-9. PubMed ID: 8853493
[TBL] [Abstract][Full Text] [Related]
8. The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Littrup PJ; Goodman AC; Mettlin CJ
CA Cancer J Clin; 1993; 43(3):134-49. PubMed ID: 7683964
[TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer. A decision analytic view.
Krahn MD; Mahoney JE; Eckman MH; Trachtenberg J; Pauker SG; Detsky AS
JAMA; 1994 Sep; 272(10):773-80. PubMed ID: 7521400
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
[TBL] [Abstract][Full Text] [Related]
11. Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).
Kranse R; Beemsterboer P; Rietbergen J; Habbema D; Hugosson J; Schröder FH
Prostate; 1999 Jun; 39(4):316-22. PubMed ID: 10344223
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
13. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of prostatic cancer with digital rectal examination, PSA determination, and endorectal echography. Correlations with the morphologic diagnosis in 200 consecutive cases].
Voisin E; Piaton E; Rivain T; Duco F
Prog Urol; 1992 Dec; 2(6):973-9. PubMed ID: 1284556
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening with PSA, DRE and TRUS.
Cusan L
Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492
[No Abstract] [Full Text] [Related]
17. Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Littrup PJ; Goodman AC; Mettlin CJ; Murphy GP
J Urol; 1994 Nov; 152(5 Pt 2):1873-7. PubMed ID: 7523734
[TBL] [Abstract][Full Text] [Related]
18. [Mass screening for prostatic cancer].
Nakagawa S; Watanabe M; Nomoto T; Sugimoto K; Mikami K; Ebisui K; Kitamura K; Kojima M; Saitoh M; Watanabe H
Hinyokika Kiyo; 1997 Jun; 43(6):447-52. PubMed ID: 9250497
[TBL] [Abstract][Full Text] [Related]
19. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
20. Early detection of prostate cancer following repeated examinations by multiple modalities: results of the American Cancer Society National Prostate Cancer Detection Project.
Mettlin C
Clin Invest Med; 1993 Dec; 16(6):440-7. PubMed ID: 7516832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
